Data were collected on the use of prescribed medication by students who were classified as profoundly mentally handicapped in a North Florida school district. It was found that 53% of the students were receiving at least one form of medication. Further analyses were conducted on the specific types of medication prescribed and the relation of prescriptions to certain demographic variables, i.e. gender, age, residence, and race. Discussion focused on the implications of the findings for public school personnel working with students with profound mental handicaps.
Get full access to this article
View all access options for this article.
References
1.
AmanM. G. (1980). Psychotropic drugs and learning problems: A selective review. Journal of Learning Disabilities, 13(2), 87–97.
2.
AmanM. G. (1983). Psychoactive drugs and mental retardation. In MatsonJ. L. & AndrasicF. (Eds.), Treatment issues and innovations in mental retardation. (pp 455–513). New York: Plenum.
3.
AmanM. G., & SinghN. N. (1980). The usefulness of thiordazine for treating childhood disorders-fact or folklore?American Journal of Mental Deficiency, 84, 331–338.
4.
AxelrodS, & BaileyS. L. (1979). Drug treatment for hyperactivity: Controversies, alternatives, and guidelines. Exceptional Children, 45, 544–550.
5.
DavisV., CullariS., & BreuningS. (1982). Drug use in community foster-group homes. In BreuningS. & PolingA. (Eds.). Drugs and mental retardation. (pp 359–376). Springfield, Illinois: Charles C. Thomas.
6.
EymanR. K., & CallT. (1977). Maladaptive behavior and community placement of mentally retarded persons. American Journal of Mental Deficiency, 82, 137–144.
7.
GadowK. D. (1980). Drug use in the public schools. In BreuningS. & PolingA. (Eds.). Drugs and Mental Retardation. (pp 330–358). Springfield, Illinois: Charles C. Thomas.
8.
GadowK. D., & KalachnikJ. (1981). Prevalence and pattern of drug treatment for behavior and seizure disorder of TMR students. American Journal of Mental Deficiency, 85, 588–595.
9.
KaufmanK. R., & Katz-GarrisL. (1979). Epilepsy, mental retardation and anti-convulsant therapy. American Journal of Mental Deficiency, 84, 256–259.
10.
LipmanR., DiMascioA., ReatigN., & KirsonT. (1978). Psychotropic drugs and mentally retarded children. In LiptonN. A., DiMascioA., & KilliamK. R. (Eds.). Psychopharmacology: A generation of progress. (pp 1437–1449). New York: Raven Press.
11.
New York Association for Retarded Citizens, Inc. v. Nelson Rockefeller No. 72 352, 72 357 (E. D. New York, 1975).
12.
SilvaD. A. (1979). The use of medication in a residential institution for mentally retarded persons. Mental Retardation, 17, 285–288.
13.
SpragueR. L. (1977a). Overview of psychopharmacology for the retarded in the United States. In MittlerP. (Ed.). Research to practice in mental retardation (Vol. III). (pp 199–202). Baltimore: University Park Press.
14.
SpragueR. L. (1977b). Psychopharmacotherapy in children. In McMillanM.Child psychiatry: Treatment and Research. (pp 130–149). New York: Brunner/Mazel.
15.
SpragueR. L., & WerryJ. S. (1971). Methodology of psychopharmacological studies with the retarded. In EllisN. R. (Ed.). International review of research in mental retardation (Vol. 5). (pp 1–50). New York: Academic Press.
16.
StoresG. (1978). Antiepileptics (anticonvulsants). In WerryJ. S. (Ed.). Pediatric psychopharmacology: The use of behavior modifying drugs in children. (pp 274–315). New York: Buner/Mazel.
17.
TuJ. B. (1979). The survey of psychotropic medication in mental retardation facilities. Journal of Clinical Psychiatry, 40, 125–128.
18.
WilsonJ. T. (1976). Special problems for drugs used in children. Southern Medical Journal, 69, 779–786.
